+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Budesonide Inhaler Market by Therapeutic Area (Asthma, Chronic Obstructive Pulmonary Disease), End Use (Adults, Pediatrics), Route, Product, Distribution Channel, Dosage Strength - Global Forecast 2025-2030- Product Image
Budesonide Inhaler Market by Therapeutic Area (Asthma, Chronic Obstructive Pulmonary Disease), End Use (Adults, Pediatrics), Route, Product, Distribution Channel, Dosage Strength - Global Forecast 2025-2030- Product Image
Sale

Budesonide Inhaler Market by Therapeutic Area (Asthma, Chronic Obstructive Pulmonary Disease), End Use (Adults, Pediatrics), Route, Product, Distribution Channel, Dosage Strength - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011478
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Budesonide Inhaler Market is witnessing robust evolution, propelled by innovative therapies and dynamic advancements in device technology. Senior decision-makers are navigating an environment characterized by therapeutic breakthroughs, changing regulatory landscapes, and growing emphasis on patient-centric care.

Market Snapshot: Budesonide Inhaler Market Size and Growth

The budesonide inhaler market grew from USD 290.37 million in 2024 to USD 317.06 million in 2025 and is expected to expand further at a CAGR of 9.11%, reaching USD 490.16 million by 2030. This upward trajectory underscores significant demand in both inhalation technologies and targeted respiratory therapies, as healthcare stakeholders strive for enhanced clinical outcomes and cost efficiency in chronic respiratory disease management.

Scope & Segmentation

This market research delves into the evolving budesonide inhaler landscape, analyzing key segments and regional nuances to highlight actionable opportunities. Major areas of coverage include:

  • Therapeutic Area: Asthma, Chronic Obstructive Pulmonary Disease
  • End Use: Adults, Pediatrics
  • Administration Route: Dry Powder Inhaler, Metered Dose Inhaler
  • Product Classification: Branded, Generic
  • Distribution Channel: Hospital Pharmacy (Government Hospital, Private Hospital), Online Pharmacy, Retail Pharmacy (Chain Pharmacy, Independent Pharmacy)
  • Dosage Strengths: High Dose, Medium Dose, Low Dose
  • Geographies Covered: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Saudi Arabia, and additional countries), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and others)
  • Leading Companies: AstraZeneca plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Amneal Pharmaceuticals, Inc., Zydus Lifesciences Ltd.

Technological innovation remains at the core, with recent years highlighting progress in smart inhalers, patient adherence solutions, and device ergonomics. Understanding these segments equips stakeholders to identify whitespace opportunities and enhance product and distribution strategies.

Key Takeaways

  • The budesonide inhaler is increasingly positioned as foundational therapy in the management of chronic respiratory diseases due to its favorable safety and efficacy profile.
  • Advancements in device engineering and formulation science are optimizing medication delivery, supporting both clinical outcomes and patient convenience.
  • Regulatory actions and payer policies are prompting pharmaceutical and device companies to prioritize innovation in design and delivery, as well as sustainability in propellant systems.
  • Integration of digital health applications is driving a more holistic approach to disease management, facilitating remote monitoring, and personalized adherence support.
  • Regional market dynamics vary markedly, requiring tailored commercialization tactics, supply chain partnerships, and portfolio adaptations.
  • Strategic collaborations among pharmaceutical firms, device manufacturers, and technology providers are accelerating the introduction of next-generation respiratory care solutions.

Tariff Impact on Budesonide Inhaler Supply Chain and Pricing

Recent tariff adjustments in the United States are reshaping supply chains for budesonide inhalers. Manufacturers are reevaluating sourcing and supplier arrangements to mitigate cost increases linked to higher import duties on active pharmaceutical ingredients and key components. This has driven nearshoring and diversification of suppliers, as well as adaptive pricing strategies among wholesalers and healthcare providers. While this environment adds layers of complexity, it also incentivizes supply chain resilience and operational innovation.

Methodology & Data Sources

The report is based on quantitative and qualitative analysis, drawing from primary interviews with clinicians, procurement experts, and patient advocates, along with secondary research from scientific literature, regulatory filings, and industry databases. Detailed segmentation and regional analyses are supported by triangulation techniques to ensure rigorous, actionable insights.

Why This Report Matters

This report offers decision-makers:

  • Clarity on evolving therapeutic, technology, and competitive landscapes for budesonide inhalers.
  • Insights into how regulatory and tariff developments are influencing procurement, supply chains, and formulation innovation.
  • Practical direction for optimizing portfolio segmentation, forging strategic partnerships, and navigating complex regional and hospital-level market access dynamics.

Conclusion

The future of the budesonide inhaler market is being shaped by digitalization, regulatory shifts, and strategic collaboration across the global respiratory care ecosystem. Industry leaders equipped with these insights will be well-positioned to drive both innovation and access, delivering value to patients and healthcare systems in this evolving environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of generic budesonide inhalers driving significant price competition across markets
5.2. Integration of digital sensor technology into budesonide inhalers to boost adherence tracking
5.3. Emergence of combination therapies pairing budesonide with long-acting bronchodilators for COPD treatment
5.4. Shift toward environmentally friendly propellant alternatives in inhaler formulation development
5.5. Growing investment in pediatric budesonide inhaler formulations to address childhood asthma needs
5.6. Impact of recent FDA guidelines on inhaled corticosteroid approval pathways for budesonide products
5.7. Advancements in patient-centric inhaler delivery systems enhancing ease of use and dosing accuracy
5.8. Rising adoption of telemedicine consultations for managing budesonide inhaler therapy adherence remotely
5.9. Proliferation of biosimilar inhaled corticosteroids challenging branded budesonide market share dynamics
5.10. Integration of real-world evidence studies to demonstrate long-term safety of budesonide inhalers in patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Budesonide Inhaler Market, by Therapeutic Area
8.1. Introduction
8.2. Asthma
8.3. Chronic Obstructive Pulmonary Disease
9. Budesonide Inhaler Market, by End Use
9.1. Introduction
9.2. Adults
9.3. Pediatrics
10. Budesonide Inhaler Market, by Route
10.1. Introduction
10.2. Dry Powder Inhaler
10.3. Metered Dose Inhaler
11. Budesonide Inhaler Market, by Product
11.1. Introduction
11.2. Branded
11.3. Generic
12. Budesonide Inhaler Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Government Hospital
12.2.2. Private Hospital
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Budesonide Inhaler Market, by Dosage Strength
13.1. Introduction
13.2. High Dose
13.3. Low Dose
13.4. Medium Dose
14. Americas Budesonide Inhaler Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Budesonide Inhaler Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Budesonide Inhaler Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AstraZeneca plc
17.3.2. Novartis AG
17.3.3. Teva Pharmaceutical Industries Ltd.
17.3.4. Viatris Inc.
17.3.5. Cipla Limited
17.3.6. Sun Pharmaceutical Industries Ltd.
17.3.7. Lupin Limited
17.3.8. Dr. Reddy's Laboratories Ltd.
17.3.9. Amneal Pharmaceuticals, Inc.
17.3.10. Zydus Lifesciences Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BUDESONIDE INHALER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BUDESONIDE INHALER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BUDESONIDE INHALER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BUDESONIDE INHALER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BUDESONIDE INHALER MARKET: RESEARCHAI
FIGURE 28. BUDESONIDE INHALER MARKET: RESEARCHSTATISTICS
FIGURE 29. BUDESONIDE INHALER MARKET: RESEARCHCONTACTS
FIGURE 30. BUDESONIDE INHALER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BUDESONIDE INHALER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUDESONIDE INHALER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BUDESONIDE INHALER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY GOVERNMENT HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY LOW DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY MEDIUM DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BUDESONIDE INHALER MARKET SIZE, BY MEDIUM DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BUDESONIDE INHALER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. CANADA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. CANADA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 100. CANADA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 101. CANADA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 102. CANADA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 103. CANADA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 104. CANADA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 105. CANADA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. CANADA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. CANADA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. CANADA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. CANADA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. CANADA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 112. CANADA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 113. MEXICO BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. MEXICO BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. MEXICO BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. MEXICO BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 124. MEXICO BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BUDESONIDE INHALER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 195. GERMANY BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 196. GERMANY BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 197. GERMANY BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 211. FRANCE BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 212. FRANCE BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 213. FRANCE BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 243. ITALY BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. ITALY BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. ITALY BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 246. ITALY BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 247. ITALY BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 248. ITALY BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 249. ITALY BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. ITALY BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. ITALY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ITALY BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ITALY BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. ITALY BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. ITALY BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ITALY BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. ITALY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. ITALY BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 259. SPAIN BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 260. SPAIN BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 261. SPAIN BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 262. SPAIN BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SPAIN BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 270. SPAIN BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 271. SPAIN BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 274. SPAIN BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 323. DENMARK BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 324. DENMARK BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 325. DENMARK BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 326. DENMARK BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK BUDESONIDE INHALER MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 330. DENMARK BUDESONIDE INHALER MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 331. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 333. DENMARK BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 334. DENMARK BUDESONIDE INHALER MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 335. DENMARK BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. DENMARK BUDESONIDE INHALER MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 338. DENMARK BUDESONIDE INHALER MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS BUDESONIDE INHALER MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS BUDESONIDE INHALER MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Budesonide Inhaler market report include:
  • AstraZeneca plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Dr. Reddy's Laboratories Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 317.06 Million
Forecasted Market Value ( USD ) by 2030 $ 490.16 Million
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Budesonide & Formoterol Inhalation Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler), Indication (Asthma, COPD), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030 - Product Image

Budesonide & Formoterol Inhalation Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhaler), Indication (Asthma, COPD), Distribution Channel, End User, Dosage Strength - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Budesonide Inhalers - Global Strategic Business Report - Product Image

Budesonide Inhalers - Global Strategic Business Report

  • Report
  • 553 Pages
  • Global
From
Budesonide & Formoterol Powder Inhalation Market by Product Type (Multi Dose DPI, Single Dose DPI), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Indication, End User, Dosage Strength - Global Forecast 2025-2030 - Product Image

Budesonide & Formoterol Powder Inhalation Market by Product Type (Multi Dose DPI, Single Dose DPI), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Indication, End User, Dosage Strength - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Budesonide Inhaler Global Market Report 2025 - Product Image

Budesonide Inhaler Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Budesonide Inhalation Aerosol Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Budesonide Inhalation Aerosol Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Inhaler Market

The Budesonide Inhaler market is a segment of the larger Respiratory Drugs market. It is composed of inhalers that contain budesonide, a corticosteroid used to treat asthma and other respiratory conditions. Budesonide inhalers are used to reduce inflammation in the airways, allowing for easier breathing. They are also used to prevent asthma attacks and reduce the severity of symptoms. Budesonide inhalers are available in both pressurized metered-dose inhalers (pMDIs) and dry powder inhalers (DPIs). The Budesonide Inhaler market is highly competitive, with many companies offering different types of inhalers. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Merck, Teva Pharmaceuticals, and Mylan. Other companies such as Boehringer Ingelheim, Novartis, and Sunovion also offer budesonide inhalers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.